Drug Shortage Report for FENTANYL CITRATE INJECTION USP

Last updated on 2022-12-28 History
Report ID 171060
Drug Identification Number 02240434
Brand name FENTANYL CITRATE INJECTION USP
Common or Proper name FENTANYL CIT
Company Name SANDOZ CANADA INCORPORATED
Market Status MARKETED
Active Ingredient(s) FENTANYL
Strength(s) 50MCG
Dosage form(s) LIQUID
Route of administration EPIDURAL INTRAVENOUS INTRAMUSCULAR EPIDURAL INTRAVENOUS INTRAMUSCULAR
Packaging size 2ML 10LIAM
ATC code N01AH
ATC description ANESTHETICS, GENERAL
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2022-10-04
Estimated end date 2022-12-16
Actual end date 2022-12-14
Shortage status Resolved
Updated date 2022-12-28
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 110 RUE DE LAUZON
BOUCHERVILLE, QUEBEC
CANADA J4B 1E6
Company contact information 1 800-361-3062

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v7 2022-12-28 French Compare
v6 2022-12-28 English Compare
v5 2022-10-26 French Compare
v4 2022-10-26 English Compare
v3 2022-10-05 English Compare
v2 2022-10-04 French Compare
v1 2022-10-04 English Compare

Showing 1 to 7 of 7